Johnson Matthey - Medical Device Components Business
Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device OEMs, serving cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications.
- Company typePublic
- Founded1817
- HeadquartersLondon, United Kingdom
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Johnson Matthey - Medical Device Components Business does
Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device original equipment manufacturers (OEMs). The business serves applications in cardiac rhythm management, neurovascular interventions, cochlear implants, and vascular interventions, supplying mission-critical components that must meet stringent biocompatibility, dimensional tolerance, and reliability standards. The product line is positioned within Johnson Matthey's broader portfolio under a dedicated "Medical-components" category accessible via the corporate product finder and a separate domain (medicaldevicecomponents.com), with ISO certificate requests managed through a dedicated contact channel, indicating the business is structured as a distinct operating unit with medical-grade quality systems.
The business draws on Johnson Matthey's foundational expertise in platinum group metals (PGM) chemistry, advanced metallurgy, and precision manufacturing — capabilities developed over more than 200 years since the company's founding in 1817. While the parent operates a diversified portfolio spanning transport (fuel cells, emissions control), energy (hydrogen, biorenewables, FCC additives, SAF), chemicals (syngas, ammonia, methanol, formaldehyde), PGMs and circularity (refining/recycling), and life science technologies, the medical device components unit specifically leverages PGM and precious-metal precision micromachining to deliver components for implantable and interventional medical devices. The product description states the components are manufactured for "cardiac rhythm management, neurovascular, cochlear, and vascular interventions," implying Class II/III medical device supply chain positioning.
The business operates a B2B enterprise sales model with direct technical engagement, regional manufacturing and distribution, and multi-year contract structures typical of mission-critical medical component supply. Pricing is quote-based and not publicly disclosed, consistent with customized industrial B2B procurement. The parent Johnson Matthey Plc is a UK public limited company listed on the London Stock Exchange (ticker: JMAT) with approximately 9,500 employees globally, operations in 25+ countries, and manufacturing facilities across the UK, US, Germany, Sweden, India, China, and Japan. The medical device components carve-out appears to be positioned as a focused, independently operable sub-business, given its distinct digital presence and dedicated compliance contact channels.
Johnson Matthey - Medical Device Components Business firmographics
Firmographics- Name
- Johnson Matthey - Medical Device Components Business
- Legal name
- Johnson Matthey Plc
- Website
- https://matthey.com
- Company type
- Public
- Founded year
- 1817
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device OEMs, serving cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications.
- Ownership category
- akta.pro rank
Where Johnson Matthey - Medical Device Components Business is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices12 records
Markets served
Johnson Matthey - Medical Device Components Business business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Catalysts and Chemical Products: Sale of catalysts, absorbents, and chemical products for industrial processes including methanol, ammonia, formaldehyde, hydrogenation, and refining applications
- Process Technology Licensing: Licensing of proprietary process technologies including methanol synthesis, formaldehyde production, syngas technologies, and hydrogen production. Provides technology packages with detailed engineering specifications.
- Fuel Cell Components: Manufacturing and sale of catalyst-coated membranes and membrane electrode assemblies for hydrogen fuel cells
- PGM Refining and Recycling: World's largest recycler of platinum group metals, offering refining and recycling services. Recovers PGMs to minimum 99.95% purity for reuse in manufacturing
- Technical Services and Support: Comprehensive technical support, catalyst optimization, plant audits, operational feedback, and performance optimization services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B enterprise pricing - customized quotes based on volume, contract terms, and specification requirements |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Johnson Matthey - Medical Device Components Business product offering
Product offeringCore offering
Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device manufacturers. The components are designed for use in cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications. As a segment of Johnson Matthey, it leverages the parent company's 200+ years of platinum group metal chemistry expertise to deliver high-precision medical components.
Product overview
Johnson Matthey is a world leader in platinum group metals (PGMs) with a 200+ year history. The company offers a diversified portfolio of products and technologies across five main segments: Transport (fuel cells, mobile emissions control), Energy (hydrogen, biorenewables, FCC additives, purification, sustainable aviation fuels), Chemicals (syngas technologies, ammonia, methanol, formaldehyde, oleochemicals, petrochemicals), PGMs and circularity (PGM chemicals, industrial products, refining and recycling), and Life science technologies (biocatalysis, pharma catalysts). The products and services span catalyst systems, process licensing technologies, purification solutions, and specialty chemical products. A 'Medical-components' category exists in their product finder but detailed product pages for medical device components are not present in the provided source data.
Differentiator
Problem solved
Functional benefit
Brands
- KATALCO: Market-leading methanol synthesis technology and catalyst brand
- FORMOX
- PURASPEC
- ActivCRT/ActivDPF
- EASY-FLO/ALU-FLO
- NONOX
- SUPER SOXGETTER/LO-SOX PB
- CAT-AID
- BCA-105
- FT CANS
- HyCOgen
- LCH/CLEANPACE
- ADEPT
- PRICAT
- SWITCH METHANOL/PRECISION METHANOL/BALANCE METHANOL/PRIMARY METHANOL
Products and services
- Medical Components Precious metal and precision micromachined components for medical device applications including cardiac rhythm management, neurovascular, cochlear, and vascular interventions.
Quantifiable outcome
- c. 112k additional tonnes NOx removed from tailpipes by JM catalytic converters in 2024/25
- +6 more outcomes
Companies that use Johnson Matthey - Medical Device Components Business
Customer profileNamed customers13 records
Segments6 records
Ideal customer profiles1 record
Johnson Matthey - Medical Device Components Business technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Johnson Matthey - Medical Device Components Business partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered flagship, core and strategic.
- bpflagshipCo-development of FT CANS (Fischer Tropsch) technology for sustainable aviation fuel production. Partnership includes Fulcrum Sierra Biofuels Plant for waste-to-fuels conversion. Also collaborating on carbon-negative renewable diesel projects and multiple SAF production plants worldwide.
- Plug PowercoreLong-term strategic partnership for green hydrogen electrolyser components. Johnson Matthey supplies PGM components and expertise for electrolyser manufacturing.
- thyssenkrupp UhdecoreIntegrated solution for blue ammonia production combining Johnson Matthey's LCH reforming technology with Uhde's ammonia process. Jointly offers catalyst and technology package for decarbonized ammonia production with up to 99% CO2 capture.
- Honeywell UOPcoreIntegrated solution for methanol to jet fuel technology combining Johnson Matthey and Honeywell UOP technologies for sustainable aviation fuel production.
- ValmetstrategicJoint development of catalytic pyrolysis technology for production of advanced biofuels. Partnership focused on renewable fuel production processes.
- VirentstrategicBioForming technology partnership that enabled the world's first transatlantic commercial flight using 100% sustainable aviation fuel, demonstrating the viability of drop-in SAF.
- KBRcoreCombined methanol/ammonia co-production technology partnership using Johnson Matthey and KBR's market-leading technologies for maximized efficiency and operational flexibility.
Scale indicators16 records
Recent moves6 records
Expansion highlights5 records
Johnson Matthey - Medical Device Components Business competitors and assessment
Company assessmentDirect peers
- Cirtec Medical: Contract manufacturer of active implantables and precision components for cardiac rhythm management, neuromodulation, and other implantable applications — comparable customer base and micromachining/assembly capabilities.
- Integer Holdings (formerly Greatbatch): Large medical device contract manufacturer specializing in precision components and finished devices for cardiac, neuromodulation, and vascular markets — directly comparable in product category and customer base.
- Tegra Medical: Contract manufacturer of precision medical devices and components including machining, assembly, and finished devices for surgical and interventional OEMs — comparable in precision-machined medical components.
- Norman Noble: Specialist in precision micromachining of medical devices and implants, including complex components for cardiovascular, neurovascular, and orthopedic applications — directly comparable on micromachining capability and customer overlap.
- Helix Medical (Freudenberg Medical): Medical device contract manufacturer of precision silicone and plastic components and finished devices for minimally invasive and surgical applications — overlaps in implantable and interventional device components.
- Minnetronix: Contract designer/manufacturer of complex medical devices and components, with strength in optical, electronic, and fluid-based systems for neuro and surgical OEMs — comparable as a specialist medtech CDMO.
- Heraeus Medical Components: Direct competitor in precious-metal components and micromachined parts for implantable medical devices (cardiac, neurovascular, hearing). Closest analog to JM's medical device components offering due to overlap in materials (Pt/Ir, Au, Ta) and implantable device applications.
Broad incumbents
- Phillips-Medisize (Molex): Large-scale medical device contract manufacturer offering design, molding, and assembly for diagnostics and drug delivery — adjacent rather than direct, but competes for the same OEM program opportunities.
- West Pharmaceutical Services: Broader medical device components manufacturer focused on elastomeric and specialty containment/delivery components; overlaps with JM medical components in supplying primary packaging and functional components to injectable and device OEMs.
- Teleflex Medical OEM: Medical device components and specialty extrusion business serving interventional, surgical, and OEM customers — broader incumbent with overlap in precision components for vascular and interventional devices.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights4 records
Customer concentration
Johnson Matthey - Medical Device Components Business social profiles
Digital presenceJohnson Matthey - Medical Device Components Business financial estimates
Financial estimateRevenue estimate
Valuation estimate
Johnson Matthey - Medical Device Components Business leadership team
Management profileNumber of profiles
Johnson Matthey - Medical Device Components Business subsidiaries and ownership
Company hierarchySubsidiaries9 records
Johnson Matthey - Medical Device Components Business funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Johnson Matthey - Medical Device Components Business M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Johnson Matthey - Medical Device Components Business
What does Johnson Matthey - Medical Device Components Business do?
Johnson Matthey's Medical Device Components Business manufactures precious metal and precision micromachined components for medical device manufacturers. The components are designed for use in cardiac rhythm management, neurovascular, cochlear, and vascular intervention applications. As a segment of Johnson Matthey, it leverages the parent company's 200+ years of platinum group metal chemistry expertise to deliver high-precision medical components.
Is Johnson Matthey - Medical Device Components Business a public or private company?
Johnson Matthey - Medical Device Components Business is a public company. It is classified as public and is currently operating.
When was Johnson Matthey - Medical Device Components Business founded?
Johnson Matthey - Medical Device Components Business was founded in 1817. It employs 5,001 to 10,000 people.
Where is Johnson Matthey - Medical Device Components Business based?
Johnson Matthey - Medical Device Components Business is headquartered in London, United Kingdom, in the Europe region.
How does Johnson Matthey - Medical Device Components Business make money?
Five revenue lines are on record. Catalysts and Chemical Products are the primary driver. The others are process Technology Licensing, fuel Cell Components, PGM Refining and Recycling and technical Services and Support.
Who are Johnson Matthey - Medical Device Components Business's main competitors?
Direct peers on record are Cirtec Medical, Integer Holdings (formerly Greatbatch), Tegra Medical, Norman Noble, Helix Medical (Freudenberg Medical), Minnetronix and Heraeus Medical Components. Broad incumbents are Phillips-Medisize (Molex), West Pharmaceutical Services and Teleflex Medical OEM.
Does Johnson Matthey - Medical Device Components Business have an API?
No public API is recorded for Johnson Matthey - Medical Device Components Business.